Albert Grinshpun Selected Research

Cell-Free Nucleic Acids

1/2023	A universal cell-free DNA approach for response prediction to preoperative chemoradiation in rectal cancer.
1/2023	Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics.
1/2022	Liquid biopsy reveals collateral tissue damage in cancer.
1/2021	ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
1/2019	Life and death of circulating cell-free DNA.
11/2018	Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Albert Grinshpun Research Topics

Disease

19	Neoplasms (Cancer) 05/2023 - 01/2017
12	Breast Neoplasms (Breast Cancer) 02/2024 - 01/2018
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2020
2	Brain Neoplasms (Brain Tumor) 05/2023 - 01/2022
2	Carcinogenesis 01/2023 - 01/2019
2	Pathologic Processes 01/2023 - 01/2021
2	Colonic Neoplasms (Colon Cancer) 01/2022 - 11/2018
2	COVID-19 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
1	Circulating Neoplastic Cells 05/2023
1	Residual Neoplasm 01/2023
1	Rectal Neoplasms (Rectal Cancer) 01/2023
1	Spontaneous Abortion (Miscarriage) 10/2020
1	Infections 01/2020
1	Inflammation (Inflammations) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019
1	Hyperglycemia 01/2019
1	Sepsis (Septicemia) 11/2018
1	Body Weight (Weight, Body) 09/2010
1	Glycogen Storage Disease Type I 09/2010
1	Hepatorenal form of glycogen storage disease 09/2010

Drug/Important Bio-Agent (IBA)

6	Cell-Free Nucleic AcidsIBA 01/2023 - 11/2018
5	Estrogen ReceptorsIBA 02/2024 - 12/2022
4	Hormones (Hormone)IBA 03/2023 - 01/2022
4	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
3	Circulating Tumor DNAIBA 05/2023 - 04/2022
2	palbociclibIBA 12/2022 - 01/2018
2	EnzymesIBA 01/2019 - 09/2010
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2024
1	snake venom protein C activatorIBA 11/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Blood Proteins (Serum Proteins)IBA 01/2023
1	Nucleosomes (Nucleosome)IBA 01/2023
1	Estrogen Receptor alphaIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	bazedoxifeneIBA 12/2022
1	Drug CombinationsIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	VaccinesIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	human ERBB2 proteinIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 10/2020
1	Advanced Glycation End ProductsIBA 01/2019
1	heparanaseIBA 01/2019
1	Everolimus FDA Link 01/2018
1	AZD4547IBA 01/2018
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2010
1	Blood Glucose (Blood Sugar)IBA 09/2010
1	Liver GlycogenIBA 09/2010

Therapy/Procedure

10	Therapeutics 02/2024 - 01/2018
1	Neoadjuvant Therapy 01/2023
1	Induced Abortion (Induced Abortions) 10/2020
1	Immunotherapy 01/2020
1	Biological Therapy 01/2020
1	Islets of Langerhans Transplantation 11/2018